These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 877560)

  • 21. Kinetic studies of the activation of factor X by factors IXa and VIII:C in the absence of thrombin.
    Neal GG; Esnouf MP
    Br J Haematol; 1984 May; 57(1):123-31. PubMed ID: 6426496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody to factor IX that inhibits the factor VIII:Ca potentiation of factor X activation.
    Bajaj SP; Rapaport SI; Maki SL
    J Biol Chem; 1985 Sep; 260(21):11574-80. PubMed ID: 3930478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa.
    McGee MP; Li LC; Hensler M
    J Exp Med; 1992 Jul; 176(1):27-35. PubMed ID: 1613461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pathway of coagulation on bovine capillary endothelial cells.
    Nawroth PP; Stern DM; Kisiel W; Dietrich M
    Br J Haematol; 1986 Jun; 63(2):309-20. PubMed ID: 3087407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
    van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
    Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.
    Lollar P; Knutson GJ; Fass DN
    Blood; 1984 Jun; 63(6):1303-8. PubMed ID: 6426549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.
    Koppelman SJ; Hackeng TM; Sixma JJ; Bouma BN
    Blood; 1995 Aug; 86(3):1062-71. PubMed ID: 7620160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.
    Eaton D; Rodriguez H; Vehar GA
    Biochemistry; 1986 Jan; 25(2):505-12. PubMed ID: 3082357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VIII influences binding of factor IX and factor X to intact human platelets.
    Muntean W; Leschnik B
    Thromb Res; 1989 Sep; 55(5):537-48. PubMed ID: 2510357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.
    Repke D; Gemmell CH; Guha A; Turitto VT; Broze GJ; Nemerson Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7623-7. PubMed ID: 2120704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation pathways: interrelationships and control mechanisms.
    Bennett B
    Semin Hematol; 1977 Jul; 14(3):301-18. PubMed ID: 69320
    [No Abstract]   [Full Text] [Related]  

  • 33. Preparation and properties of bovine factor VIII (antihemophilic factor).
    Vehar GA; Davie EW
    Biochemistry; 1980 Feb; 19(3):401-10. PubMed ID: 7356933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
    Chang P; Aronson DL; Borenstein DG; Kessler CM
    Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA).
    Estry DW; Tishkoff GH
    Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of human factor VII by activated factors IX and X.
    Masys DR; Bajaj SP; Rapaport SI
    Blood; 1982 Nov; 60(5):1143-50. PubMed ID: 7126868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular interactions of the intrinsic activation complex of coagulation: binding of native and activated human factors IX and X to defined phospholipid vesicles.
    Burri BJ; Edgington TS; Fair DS
    Biochim Biophys Acta; 1987 Feb; 923(2):176-86. PubMed ID: 3493031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.